Discover 1,807 paid clinical trials in Escondido, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,807
Study With [225Ac]Ac-FL-020 in mCRPC Participants
for
Metastatic Castration-resistant Prostate Cancer
Location: Irvine CA, Duarte CA, Stanford CA, Cleveland OH,
Sponsor: Full-Life Technologies GmbH
Sex: Male
Age: 18+
Code: NCT06492122
Phase 1, Recruiting
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
for
Carcinoma, Non-Small-Cell Lung,
Location: Irvine CA, Orange CA, Sacramento CA,
Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Sex: All
Age: 18+
Code: NCT05208762
Phase 1, Recruiting
Testing the Combination of the Anti-Cancer Drugs Temozolomide and M1774 to Evaluate Their Safety and Effectiveness
for
Advanced Malignant Solid Neoplasm,
Location: Irvine CA, Orange CA, Oklahoma City OK,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT05691491
Phase 1, Phase 2, Recruiting
Testing the Addition of an Anti-Cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment (Capecitabine) for Metastatic or Unresectable Cancers
for
Metastatic Colorectal Carcinoma,
Location: Irvine CA, Orange CA, Oklahoma City OK, Fairway KS,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT05803382
Phase 1, Recruiting
Testing the Addition of Abemaciclib to Olaparib for Women With Recurrent Ovarian Cancer
for
Recurrent Ovarian High Grade Serous Adenocarcinoma,
Location: Irvine CA, Orange CA, Los Angeles CA, Oklahoma City OK,
Sponsor: National Cancer Institute (NCI)
Sex: Female
Age: 18+
Code: NCT04633239
Phase 1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Testing the Addition of Sunitinib Malate to Lutetium Lu 177 Dotatate (Lutathera) in Pancreatic Neuroendocrine Tumors
Location: Irvine CA, Orange CA, City of Saint Peters MO,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT05687123
Phase 1, Recruiting
Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)
for
Myelodysplastic Syndrome
Location: Irvine CA, Orange CA, Salt Lake City UT, Albuquerque NM,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06577441
Phase 2, Recruiting
Testing the Addition of an Anti-Cancer Drug, Abemaciclib, to the Usual Chemotherapy Treatment (5-Fluorouracil) for Metastatic, Refractory Colorectal Cancer
Location: Irvine CA, Orange CA, Cincinnati OH, West Chester OH,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06654037
Phase 1, Recruiting
Neoadjuvant Chemotherapy, Excision And Observation vs Chemoradiotherapy For Rectal Cancer
for
Rectal Cancer
Location: Irvine CA, Orange CA, Los Angeles CA, Santa Maria CA,
Sponsor: Canadian Cancer Trials Group
Sex: All
Age: 18+
Code: NCT06205485
Phase 3, Recruiting
New
Testing Short-Course Radiation Versus Standard-Course Radiation for Soft Tissue Sarcomas That Need Surgery and Radiation
for
Recurrent Soft Tissue Sarcoma of the Trunk and Extremities,
Location: Irvine CA, Orange CA, Anaheim CA, Ontario CA,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT07615049
Phase 3, Recruiting
A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer
for
Pancreatic Cancer, Metastatic Pancreatic Cancer,
Location: Irvine CA, Newport Beach CA, Orange CA, Fullerton CA,
Sponsor: Astellas Pharma Global Development, Inc.
Sex: All
Age: 18+
Code: NCT07409272
Phase 3, Recruiting
Elranatamab Post Trial Access Study for Participants With Multiple Myeloma (MM)
for
Multiple Myeloma
Location: Irvine CA, Orange CA, Longmont CO, Loveland CO,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT06057402
Recruiting
A Dose-masked Study of Intravitreal EYE103 in Participants With NVAMD or Macular Edema Following BRVO